Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
Total Assets
Sonoma Pharmaceuticals Inc
Total Assets Peer Comparison
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Total Assets
$14.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
4%
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Assets
$172B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Assets
$99B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
23%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Total Assets
$226.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Assets
$105.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Assets
$63.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
See Also
What is Sonoma Pharmaceuticals Inc's Total Assets?
Total Assets
14.6m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Total Assets amounts to 14.6m USD.
What is Sonoma Pharmaceuticals Inc's Total Assets growth rate?
Total Assets CAGR 10Y
4%
Over the last year, the Total Assets growth was 5%. The average annual Total Assets growth rates for Sonoma Pharmaceuticals Inc have been -7% over the past three years , -3% over the past five years , and 4% over the past ten years .